Literature DB >> 31602632

Deciphering molecular heterogeneity of Indian families with hereditary spherocytosis using targeted next-generation sequencing: First South Asian study.

Anu Aggarwal1, Manu Jamwal1, Prashant Sharma1, Man Updesh Singh Sachdeva1, Deepak Bansal2, Pankaj Malhotra3, Reena Das1.   

Abstract

Defects in various erythrocyte membrane proteins genes (ankyrin, band-3, β- and α-spectrin and protein 4·2) can cause hereditary spherocytosis (HS). This molecular heterogeneity of HS, together with co-inherited genetic modifiers, results in marked phenotypic variability among patients. We studied the molecular spectrum and genotype-phenotype correlations in 73 families (with 113 patients) with HS. Deleterious variants including nonsense (42%), deletions (18%), splice site (20%), missense (10%) and duplication/insertion (10%) were found in 47 patients. The variants detected included sporadic and dominantly-inherited defects in ANK1 (53·2%), SPTB (36·2%) and SLC4A1 (4·2%). Compound heterozygous variants in SPTA1 (6·4%) showed autosomal recessive inheritance. Alpha-spectrin variants were associated with severe anaemia and splenectomy alleviated symptoms. Co-inherited glucose-6-phosphate dehydrogenase (G6PD) deficiency was found in 15%. G6PD variants (n = 5) led to greater transfusion requirements (1-8 times) in males with HS. Homozygosity (41%) for the promoter variant of UGT1A1 (Gilbert syndrome) led to a significantly higher mean bilirubin level (126·54 µmol/l) with a higher frequency of cholelithiasis (30%) (P < 0·001). This first-ever south Asian study on the molecular spectrum of HS found ANK1 and SPTB genes variants to be the commonest with inheritance being sporadic/dominant. Next-generation sequencing provided a relatively sensitive and rapid tool for molecular diagnosis with a diagnostic yield of 64·4%.
© 2019 British Society for Haematology and John Wiley & Sons Ltd.

Entities:  

Keywords:  ankyrin; hereditary spherocytosis; α-spectrin and Band-3; β-spectrin

Year:  2019        PMID: 31602632     DOI: 10.1111/bjh.16244

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  5 in total

1.  Influence of UGT1A1 promoter polymorphism, α-thalassemia and βs haplotype in bilirubin levels and cholelithiasis in a large sickle cell anemia cohort.

Authors:  Jéssica V G F Batista; Gabriela S Arcanjo; Thais H C Batista; Marcondes J Sobreira; Rodrigo M Santana; Igor F Domingos; Betânia L Hatzlhofer; Diego A Falcão; Diego A Pereira-Martins; Jéssica M Oliveira; Amanda S Araujo; Luana P M Laranjeira; Fernanda S Medeiros; Flávia P Albuquerque; Dulcinéia M Albuquerque; Magnun N Santos; Manuela F Hazin; Ana C Dos Anjos; Fernando F Costa; Aderson S Araujo; Antonio R Lucena-Araujo; Marcos A Bezerra
Journal:  Ann Hematol       Date:  2021-02-01       Impact factor: 3.673

2.  A novel SPTB mutation causes hereditary spherocytosis via loss-of-function of β-spectrin.

Authors:  Shan Li; Ping Guo; Leyuan Mi; Xiaojing Chai; Kewang Xi; Ting Liu; Li Lu; Juan Li
Journal:  Ann Hematol       Date:  2022-01-31       Impact factor: 3.673

3.  Facilitating EMA binding test performance using fluorescent beads combined with next-generation sequencing.

Authors:  Andreas Glenthøj; Christian Brieghel; Amina Nardo-Marino; Richard van Wijk; Henrik Birgens; Jesper Petersen
Journal:  EJHaem       Date:  2021-09-09

Review 4.  Genetics and Genomics Approaches for Diagnosis and Research Into Hereditary Anemias.

Authors:  Roberta Russo; Roberta Marra; Barbara Eleni Rosato; Achille Iolascon; Immacolata Andolfo
Journal:  Front Physiol       Date:  2020-12-22       Impact factor: 4.566

5.  Preliminary Study on the Clinical and Genetic Characteristics of Hereditary Spherocytosis in 15 Chinese Children.

Authors:  Chongjun Wu; Ting Xiong; Zhongjin Xu; Chunlei Zhan; Feng Chen; Yao Ye; Hong Wang; Yu Yang
Journal:  Front Genet       Date:  2021-03-18       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.